DNA Script

233 employees

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Synthetic Biology

Life Science

Technology

Research

DNA synthesis

Medical

Health Care

Start-up

Development

Sciences

Date founded

2014

Funding rounds raised

Total raised

$200M

from 30 investors over 30 rounds

DNA Script raised undisclosed on August 27, 2022

Investors: Hedonova

DNA Script raised $200M on January 4, 2022

Investors: T. Rowe Price, Casdin Capital, LLC, HealthCor Management, L.P., eureKARE, Irving Investors, Coatue Management, HEALTHCOR LTD, Catalio Capital Management and Columbia Threadneedle Investments EMEA APAC

DNA Script raised $165M on October 26, 2021

Investors: Farallon Capital Management, Illumina Ventures, Columbia Threadneedle Investments EMEA APAC, M Ventures, EQT Life Sciences and Coatue Management

DNA Script raised $50M on July 29, 2020

Investors: Casdin Capital, LLC, M Ventures, Illumina Ventures and EQT Life Sciences

DNA Script raised $39M on May 16, 2019

Investors: Illumina Ventures, Idinvest Partners, EQT Life Sciences and Sofinnova Partners

DNA Script raised $13M on September 12, 2017

Investors: M Ventures, Idinvest Partners, Illumina Ventures and Sofinnova Partners

DNA Script raised $2.8M on June 30, 2016

Investors: Idinvest Partners and Sofinnova Partners